13th Annual Comprehensive Hematology and Oncology Review Course 2022

13th Annual Comprehensive Hematology and Oncology Review Course 2022

Regular price
$65.00
Sale price
$65.00
Regular price
Sold out
Unit price
per 

Format : 54 Videos + 54 PDFs




File Size : 7.02 GB



Learn more about data supporting guidelines, recommendations and recent advances regarding therapeutic options for patients with solid tumors and malignant and nonmalignant hematologic disorders.


On completing the program, learners will gain a deeper understanding of the pathogenesis, diagnostic evaluation and therapeutic modalities available for a breadth of solid tumors and hematologic disorders, and the ability to integrate guideline-based treatments, new therapeutic modalities and diagnostic approaches into clinical practice.


This educational program is intended for physicians, advanced practice providers, nurses, pharmacists, residents and fellows interested in a comprehensive update on solid tumors and hematologic disorders, and will be of interest to those certifying or re-certifying for their boards.


Topics : 





Breast oncology











Breast Cancer – Adjuvant Therapy





















Breast Cancer – Metastatic

























Breast Cancer – Non-Invasive




















GI oncology











Anal Cancer

























Cholangiocarcinoma





















Colorectal Cancer





















Esophageal/Gastric Cancer





















Gastrointestinal Neuroendocrine Tumors





















Hepatocellular Cancer





















Pancreatic Cancer
















GU oncology











Bladder Cancer





















Prostate Cancer





















Renal Cell Carcinoma





















Testicular Cancer
















Gynecologic oncology











Gynecologic Oncology – Cervical and Endometrial Cancers

























Gynecologic Oncology – Ovarian Cancer
























Hematology











Benign White Cell Disorders

























Bleeding Disorders





















Hematopoietic Stem Cell Transplantation





















Inherited & Acquired Marrow Failure





















Iron Metabolism Disorders & Hemolytic Anemias





















Myelodysplastic Syndromes





















Myeloproliferative Neoplasms





















Thalassemia & Hemoglobinopathies





















Thrombocytopenia





















Thrombosis & Anticoagulation





















Thrombotic Microangiopathies (TTP/aHUS)





















Transfusion Medicine





















Consultative Hematology
















Leukemia & myelomas











Acute Lymphoblastic Leukemia





















Acute Myeloid Leukemia





















Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) & Hairy Cell Leukemia





















Chronic Myeloid Leukemia





















MGUS & Smoldering Myeloma





















Multiple Myeloma





















Lymphomas











Aggressive Non-Hodgkin Lymphoma





















Hodgkin Lymphoma





















Indolent Non-Hodgkin Lymphoma





















T-Cell Lymphoma
















Melanoma











Melanoma and other Skin Cancers





















Neuro-oncology











CNS Cancers





























Sarcomas











Sarcoma




















Supportive care & associated specialties











Familial Syndromes



















Infectious Disease Complications





















Integrative Oncology





















Pharmacology I





















Pharmacology II





















Radiation Oncology – Multi-disciplinary (Breast, Lung, Colorectal, and Palliative)





















Supportive Care
















Thoracic, head and neck oncology











Head, Neck & Thyroid Cancer





















Mesothelioma





















Non-Small Cell Lung Cancer – Adjuvant/Locally Advanced





















Non-Small Cell Lung Cancer – Metastatic





















Small Cell Lung Cancer